Bioventus (BVS) Revenue (QoQ) (2020 - 2026)
Bioventus (BVS) Revenue (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | Bioventus | 972.23 Mn | 942.77 Mn | 105.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 15.99% |
| Mar 28, 2026 | -16.35% |
| Dec 31, 2025 | 13.88% |
| Sep 27, 2025 | -6.10% |
| Jun 28, 2025 | 19.20% |
| Mar 29, 2025 | -19.37% |
| Dec 31, 2024 | 10.56% |
| Sep 28, 2024 | -8.10% |
| Jun 29, 2024 | 16.81% |
| Mar 30, 2024 | -4.41% |
| Dec 31, 2023 | 12.11% |
| Sep 30, 2023 | -11.87% |
| Jul 1, 2023 | 15.13% |
| Apr 1, 2023 | -5.38% |
| Dec 31, 2022 | -2.20% |
| Oct 1, 2022 | -8.32% |
| Jul 2, 2022 | 19.64% |
| Apr 2, 2022 | -10.06% |
| Dec 31, 2021 | 19.77% |
| Oct 2, 2021 | -0.84% |